Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "valsartan"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"330 - Economics"
Showing
1
-
1
of
1
Search:
'"valsartan"'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Pharmacoeconomic report: Dapagliflozin (Forxiga) : (AstraZeneca Canada Inc.) : indication: heart failure with reduced ejection fraction
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
... of DAPA +ST and sacubitril-
valsartan
plus standard therapy (SAC-VAL + ST), the cost-effectiveness of DAPA...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 330 - Economics
Year of Publication
From:
To:
Classification
330 - Economics
Language
English
1
Collection
National Center for Biotechnology Information
1
Author
Canadian Agency for Drugs and Technologies in Health
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&lookfor=%22valsartan%22&type=AllFields
Send by Email
×
Loading...